ESPA Biomedical Products and Cannabis for Peak Efficacy

In the context of the multi-functionality of our products, an opportunity has developed to assess synergistic action between certain ESPA Biomedical products with cannabidiol (CBD).

Effects on the endocannabinoid system (ECS) is thought to become a focal point of the research and development of therapeutic agents.

Inflammation and impaired immune function are common biochemical targets for ESPA Biomedical products and CBD.

Anorectal Product and Projects

Innovative Herbal-based Remedies

  • Anal Fissure
  • Thrombotic Hemorrhoids
  • Post Operative Pain

Project Aims

The project is to fulfill a great need to find more effective non-surgical and safe treatment modalities, utilizing multifunctional, herbal-based natural formulations developed by the ESPA Biomedical R&D team.

The project is conducted in association with internationally recognised clinical specialists.

Status

  • Anal fissure product is registered and approved by the Israel Ministry of Health
  • Clinical trial in preparation
  • Small scale production for trial in progress
  • Estimated time to market by Q4 2020

The products on this website are not drugs and are not intended to diagnose, treat or prevent any disease.